IP Library Granted Patent US 12,076,533
Granted Patent B2
US 12,076,533 · App. 17/645,693 · Granted Sep 3, 2024

Contextual adjustment of insulin absorption curves

Inventors: Boyi Jiang (Pasadena, CA); Yuxiang Zhong (Arcadia, CA); Pratik J. Agrawal (Porter Ranch, CA)
Assignee: MEDTRONIC MINIMED, INC.
A61M5/1723A61M5/1452G16H10/60G16H20/17A61M2205/50A61M2205/8206A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,076,533
App. No.
17/645,693
Granted
Sep 3, 2024
Kind
B2
Abstract

A processor-implemented method includes identifying a reference insulin absorption curve for a patient based on demographic data of the patient, identifying a contextual adjustment factor based on current contextual information for the patient, obtaining an adjusted insulin absorption curve based on the reference insulin absorption curve and the contextual adjustment factor, and causing insulin delivery to the patient based on the adjusted insulin absorption curve.

Claims (40)

1. A processor-implemented method comprising:

identifying a reference insulin absorption curve for a patient based on demographic data of the patient;

identifying a contextual adjustment factor based on current contextual information for the patient;

obtaining an adjusted insulin absorption curve based on the reference insulin absorption curve and the contextual adjustment factor; and

causing insulin delivery to the patient based on the adjusted insulin absorption curve.

2. The method of claim 1 , wherein obtaining the adjusted insulin absorption curve comprises:

providing the reference insulin absorption curve and the contextual adjustment factor as inputs to an insulin absorption model; and

obtaining the adjusted insulin absorption curve based on the insulin absorption model.

3. The method of claim 2 , wherein the insulin absorption model is derived based on application of machine learning to analyze relationships between historical insulin on board (IOB) time series data, historical contextual adjustment factor data, and historical reference insulin absorption curves associated with prior bolus events.

4. The method of claim 3 , wherein the historical IOB time series data is optimized based on minimizing cumulative differences between simulated glucose levels and historical glucose measurement data of the patient.

5. The method of claim 1 , wherein the reference insulin absorption curve is associated with a patient cluster corresponding to the patient's demographic data.

6. The method of claim 1 , wherein the contextual adjustment factor is determined based on providing the current contextual information as input to a model for predicting how the current contextual information will affect an insulin absorption rate of the patient, and identifying the contextual adjustment factor based on the model.

7. The method of claim 1 , wherein the current contextual information includes at least one of a group comprising a time of day, a day of the week, a geographic location, and an activity level of the patient.

8. A system comprising:

one or more processors; and

one or more processor-readable storage media storing instructions which, when executed by the one or more processors, cause performance of:

identifying a reference insulin absorption curve for a patient based on demographic data of the patient;

identifying a contextual adjustment factor based on current contextual information for the patient;

obtaining an adjusted insulin absorption curve based on the reference insulin absorption curve and the contextual adjustment factor; and

causing insulin delivery to the patient based on the adjusted insulin absorption curve.

9. The system of claim 8 , wherein obtaining the adjusted insulin absorption curve comprises:

providing the reference insulin absorption curve and the contextual adjustment factor as inputs to an insulin absorption model; and

obtaining the adjusted insulin absorption curve based on the insulin absorption model.

10. The system of claim 9 , wherein the insulin absorption model is derived based on application of machine learning to analyze relationships between historical insulin on board (IOB) time series data, historical contextual adjustment factor data, and historical reference insulin absorption curves associated with prior bolus events.

11. The system of claim 10 , wherein the historical IOB time series data is optimized based on minimizing cumulative differences between simulated glucose levels and historical glucose measurement data of the patient.

12. The system of claim 8 , wherein the reference insulin absorption curve is associated with a patient cluster corresponding to the patient's demographic data.

13. The system of claim 8 , wherein the contextual adjustment factor is determined based on providing the current contextual information as input to a model for predicting how the current contextual information will affect an insulin absorption rate of the patient, and identifying the contextual adjustment factor based on the model.

14. The system of claim 8 , wherein the current contextual information includes at least one of a group comprising a time of day, a day of the week, a geographic location, and an activity level of the patient.

15. One or more processor-readable storage media storing instructions which, when executed by one or more processors, cause performance of:

identifying a reference insulin absorption curve for a patient based on demographic data of the patient;

identifying a contextual adjustment factor based on current contextual information for the patient;

obtaining an adjusted insulin absorption curve based on the reference insulin absorption curve and the contextual adjustment factor; and

causing insulin delivery to the patient based on the adjusted insulin absorption curve.

16. The one or more processor-readable storage media of claim 15 , wherein obtaining the adjusted insulin absorption curve comprises:

providing the reference insulin absorption curve and the contextual adjustment factor as inputs to an insulin absorption model; and

obtaining the adjusted insulin absorption curve based on the insulin absorption model.

17. The one or more processor-readable storage media of claim 16 , wherein the insulin absorption model is derived based on application of machine learning to analyze relationships between historical insulin on board (IOB) time series data, historical contextual adjustment factor data, and historical reference insulin absorption curves associated with prior bolus events.

18. The one or more processor-readable storage media of claim 17 , wherein the historical IOB time series data is optimized based on minimizing cumulative differences between simulated glucose levels and historical glucose measurement data of the patient.

19. The one or more processor-readable storage media of claim 15 , wherein the reference insulin absorption curve is associated with a patient cluster corresponding to the patient's demographic data.

20. The one or more processor-readable storage media of claim 15 , wherein the contextual adjustment factor is determined based on providing the current contextual information as input to a model for predicting how the current contextual information will affect an insulin absorption rate of the patient, and identifying the contextual adjustment factor based on the model.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2021
From: JIANG, BOYI; ZHONG, YUXIANG; AGRAWAL, PRATIK J.
To: MEDTRONIC MINIMED, INC.
Reel/Frame 058465/0102 →